Saloni Chopra
PhD student at Department of Immunology, Genetics and Pathology; Research programme: Cancer Precision Medicine; Research group Marika Nestor
- E-mail:
- saloni.chopra@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA
Publications
Recent publications
-
[161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
Part of EJNMMI Research, 2026
- DOI for [161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
- Download full text (pdf) of [161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
-
Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
Part of Endocrine, p. 626-637, 2024
- DOI for Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
- Download full text (pdf) of Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
-
Part of Cancers, 2023
- DOI for Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts
- Download full text (pdf) of Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts
All publications
Articles in journal
-
[161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
Part of EJNMMI Research, 2026
- DOI for [161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
- Download full text (pdf) of [161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
-
Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
Part of Endocrine, p. 626-637, 2024
- DOI for Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
- Download full text (pdf) of Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
-
Part of Cancers, 2023
- DOI for Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts
- Download full text (pdf) of Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts